Records 1 - 30
| A Study of Nuclear Factor-Kappa B1 Gene Polymorphism Types in Schizophrenia Patients and Their Correlation With Disease Severity.
Cureus 2022 Apr 14 (4): e24401.
Swain Susree A, Sarangi Pratikhya, Rattan Roma, Sahu Pratima K, Lamare Andrew
| Association between single nucleotide polymorphisms in non-coding regions of the insulin (INS) gene and schizophrenia.
Neuro endocrinology letters 2022 Apr 43 (1): .
Authors are not available
| Association between TLR2 polymorphisms (-?196-174 Ins/Del, R677W, R753Q, and P631H) and schizophrenia in a Tunisian population.
Immunologic research 2021 Sep .
Aflouk Youssef, Inoubli Oumaima, Saoud Hana, Zaafrane Ferid, Gaha Lotfi, Bel Hadj Jrad Bes
| Association between dopamine beta-hydroxylase polymorphism and attention function in suicide attempters with chronic schizophrenia.
Human psychopharmacology 2020 Sep e2755.
Hui Li, Hu Wei Ming, Zhu Zhen Hua, Gao Song Tian, Han Mei, Fan Yu, Tian Qing, Yin Xu Yuan, Yuan Ying, Jiang Cai Xia, Yin Guang Zhong, Jia Qiu Fang, Zhang Xiang Ya
| Association of regulatory variants of dopamine ß-hydroxylase with cognition and tardive dyskinesia in schizophrenia subjects.
Journal of psychopharmacology (Oxford, England) 2020 Jan 269881119895539.
Punchaichira Toyanji J, Mukhopadhyay Anirban, Kukshal Prachi, Bhatia Triptish, Deshpande Smita N, Thelma B
| Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia.
Psychiatry research 2019 Jun 278 135-140.
Funahashi Yu, Yoshino Yuta, Yamazaki Kiyohiro, Ozaki Yuki, Mori Yoko, Mori Takaaki, Ochi Shinichiro, Iga Jun-Ichi, Ueno Shu-Ic
| Cyfip1 Haploinsufficiency Does Not Alter GABA Receptor d-Subunit Expression and Tonic Inhibition in Dentate Gyrus PV Interneurons and Granule Cells.
eNeuro 2019 Jun .
Trent Simon, Hall Jeremy, Connelly William M, Errington Adam
| Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia.
Fundamental & clinical pharmacology 2019 Jun 33 (3): 355-364.
Alladi Charanraj Goud, RajKumar Ravi Philip, Adithan Surendiran, Marie-Claire Cynthia, Bellivier Frank, Shewade Deepak Gop
| Association between a 50bp Ins/Del polymorphism at the promoter region of the superoxide dismutase-1 and age of onset of schizophrenia.
EXCLI journal 2019 18 204-206.
Mirsadraee Niloufar, Saadat Mosta
| Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.
Basic & clinical pharmacology & toxicology 2018 Aug .
Ma Lingyue, Zhang Xiaodan, Xiang Qian, Zhou Shuang, Zhao Nan, Xie Qiufen, Zhao Xia, Zhou Ying, Cui Yim
| Effects of the -141C insertion/deletion polymorphism in the dopamine D2 receptor gene on the dopamine system in the striatum in patients with schizophrenia.
Psychiatry research 2018 06 264 116-118.
Matsumoto Junya, Nagaoka Atsuko, Kunii Yasuto, Miura Itaru, Hino Mizuki, Niwa Shin-Ichi, Nawa Hiroyuki, Takahashi Hitoshi, Kakita Akiyoshi, Yabe Hiroo
| Influence of correlation between HLA-G polymorphism and Interleukin-6 (IL6) gene expression on the risk of schizophrenia.
Cytokine 2017 Dec .
Shivakumar Venkataram, Debnath Monojit, Venugopal Deepthi, Rajasekaran Ashwini, Kalmady Sunil V, Subbanna Manjula, Narayanaswamy Janardhanan C, Amaresha Anekal C, Venkatasubramanian Ganes
| The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.
Translational psychiatry 2017 04 7 (4): e1091.
Smith C T, Dang L C, Buckholtz J W, Tetreault A M, Cowan R L, Kessler R M, Zald D
| The impact of HLA-G 3' UTR variants and sHLA-G on risk and clinical correlates of schizophrenia.
Human immunology 2016 Dec 77 (12): 1166-1171.
Rajasekaran Ashwini, Shivakumar Venkataram, Kalmady Sunil V, Narayanaswamy Janardhanan C, Subbana Manjula, Venugopal Deepthi, Amaresha Anekal C, Venkatasubramanian Ganesan, Berk Michael, Debnath Monoj
| Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
Schizophrenia research 2016 Oct .
Hui Li, Han Mei, Yin Guang Zhong, Zhang Yingyang, Huang Xu Feng, Qian Zheng Kang, Gu Wei Guo, Gu Xiao Chu, Zhu Xiao Min, Soares Jair C, Ning Yuping, Zheng Yingjun, Du Xiang Dong, Zhang Xiang Ya
| Lack of Association Between Dopamine Beta-Hydroxylase (DBH) 19-bp Insertion/Deletion Polymorphism and Risk of Schizophrenia.
Iranian journal of psychiatry 2016 Oct 11 (4): 239-243.
Shakiba Mansour, Hashemi Mohammad, Shahrabadi Sara, Rezaei Maryam, Taheri Mohs
| The -141C Ins/Del and Taq1A polymorphism in the dopamine D2 receptor gene may confer susceptibility to schizophrenia in Asian populations.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2016 Aug 30 1-7.
Wang Yurong, Liu Li, Xin Lihong, Fan Dazhi, Ding Ning, Hu Yanting, Cai Guoqi, Wang Li, Xia Qing, Li Xiaona, Yang Xiao, Zou Yanfeng, Pan Fami
| Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis.
Psychoneuroendocrinology 2016 Jun 72 1-10.
Miura Itaru, Zhang Jian-Ping, Hagi Katsuhiko, Lencz Todd, Kane John M, Yabe Hirooki, Malhotra Anil K, Correll Christoph
| Association between DßH 5'-insertion/deletion polymorphism and cognition in patients with chronic schizophrenia.
The Journal of clinical psychiatry 2016 Mar 77 (3): 379-85.
Hui Li, Han Mei, Huang Xu Feng, Ye Min Jie, Zhang Xuan, He Jin Cai, Lv Meng Han, Soares Jair C, Zhang Xiang Ya
| -141C insertion/deletion polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in Chinese Han population: Evidence from an ethnic group-specific meta-analysis.
Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists 2015 Sep .
Zhao Xiaofeng, Huang Yinglin, Chen Kaiyuan, Li Duolu, Han Chao, Kan Quanche
| Influence of -141C Ins/Del Polymorphism in DRD2 Gene on Clinical Symptoms and Plasma Homovanillic Acid Levels in the Treatment of Schizophrenia With Aripiprazole.
Journal of clinical psychopharmacology 2015 Jun 35 (3): 333-4.
Miura Itaru, Kanno-Nozaki Keiko, Hino Mizuki, Horikoshi Sho, Ota Takafumi, Mashiko Hirobumi, Niwa Shin-Ichi, Yabe Hiroo
| Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia.
Journal of neural transmission (Vienna, Austria : 1996) 2015 Jun 122 (6): 907-14.
Hui Li, Han Mei, Huang Xu Feng, Ye Min Jie, Zheng Ke, He Jin Cai, Lv Meng Han, Zhang Bao Hua, Soares Jair C, Zhang Xiang Ya
| Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons.
Molecular psychiatry 2015 Feb 20 (2): 162-9.
Yoshimizu T, Pan J Q, Mungenast A E, Madison J M, Su S, Ketterman J, Ongur D, McPhie D, Cohen B, Perlis R, Tsai L
| Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia.
Biomedical reports 2014 Sep 2 (5): 729-736.
Dai Dongjun, Wang Yunliang, Yuan Jiaojiao, Zhou Xingyu, Jiang Danjie, Li Jinfeng, Zhang Yuzheng, Yin Honglei, Duan Shiw
| Lack of association between dopamine-ß hydroxylase gene and a history of suicide attempt in schizophrenia: comparison of molecular and statistical haplotype analyses.
Psychiatric genetics 2014 Jun 24 (3): 110-5.
Howe Aaron S, Leung Tiffany, Bani-Fatemi Ali, Souza Renan, Tampakeras Maria, Zai Clement, Kennedy James L, Strauss John, De Luca Vincen
| Functional -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter and schizophrenia in a Chinese Han population.
The Journal of international medical research 2013 Aug 41 (4): 1171-8.
Xiao Ling, Shen Ting, Peng Dai-hui, Shu Chang, Jiang Kai-da, Wang Gao-h
| Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients.
Schizophrenia research 2013 May .
Hui L, Zhang X, Yu YQ, Han M, Huang XF, Chen DC, Wang ZR, Du WL, Kou CG, Yu Q, Kosten TR, Zhang XY
| Association of the dopamine ß-hydroxylase 19 bp insertion/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia.
Human psychopharmacology 2013 May 28 (3): 230-7.
Zhou Na, Yu Qiong, Li Xiaokun, Yu Yaqin, Kou Changgui, Li Wenjun, Xu Hongqin, Luo Xingguang, Zuo Lingjun, Kosten Thomas R, Zhang Xiang Ya
| Association between polymorphisms in the genes for tumor suppressor protein p53 and its regulator NAD(P)H: quinone oxidoreductase 1 (NQO1) and schizophrenia in a Syrian study cohort.
Archives of medical research 2013 Jan .
Lajin B, Alachkar A, Michati R, Sakur AA
| Risperidone-Induced Adverse Drug Reactions and Role of DRD2 (-141 C Ins/Del) and 5HTR2C (-759 C>T) Genetic Polymorphisms in Patients with Schizophrenia.
Journal of pharmacology & pharmacotherapeutics 0 8 (1): 28-32.
Alladi Charanraj Goud, Mohan Anbarasan, Shewade Deepak Gopal, Rajkumar Ravi Philip, Adithan Surendiran, Subramanian Karthi